Fineotex Chemical Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
FCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 21.6 pts more than Nifty Microcap 250 and 21.9 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fineotex Chemical reported strong FY2025-26 consolidated results with revenue growing 44.79% to Rs. 772.23 Crores and PAT rising 14.50% to Rs. 125.01 Crores. Q4 showed particularly robust growth with revenue up 161.91% YoY to Rs. 313.73 Crores and PAT up 117.56% to Rs. 43.80 Crores. EBITDA for Q4 grew 85.87% YoY. The company declared total dividend of Rs. 14.98 Crores for FY26 versus Rs. 9.16 Crores in prior year. The statutory auditors issued unmodified (clean) audit opinions for both standalone and consolidated results. Return on Invested Capital stood at 31.10%. However, operating cash flow turned negative at Rs. -2.38 Crores on consolidated basis compared to Rs. 6.93 Crores positive in FY25, indicating working capital pressure despite profit growth.
The company delivered strong top-line and bottom-line growth, with clean audit opinions supporting financial quality. However, the negative operating cash flow despite profit growth may concern investors focused on earnings quality, though strong ROIC and dividend growth remain positive signals.